Characterization of the biological effect of fish fibrin glue in experiments on rats: Immunological and coagulation studies

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 1, 2010, Pages 29-36

  Laidmäe, Ivo ^a,b   Salum, Tiit ^b,c   Sawyer, Evelyn S ^d   Janmey, Paul A ^e   Uibo, Raivo ^a,b  

^a UNIVERSITY OF TARTU   (Estonia)

^b Tartu Science Park ^*  (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d Sea Run Holdings Inc   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Animal experiments; Antibodies; Coagulation; Fibrin glue; Thrombin time

Indexed keywords

ANIMAL EXPERIMENTS; BIOLOGICAL EFFECTS; CELL THERAPY; FIBRIN GLUE; FIBRIN SEALANTS; HAEMOSTASIS; HUMAN FACTORS; IMMUNOBLOTS; INTRAPERITONEALLY; MEDICAL USE; PERIPHERAL BLOOD; PLASMA PRODUCTS; PLASMA PROTEIN; THROMBIN TIME; WISTAR RAT; WOUND HEALING;

ANIMALS; BLOOD; COAGULATION; EXPERIMENTS; GLUES; GLUING; HUMAN ENGINEERING; RATS; TISSUE ENGINEERING; VIRUSES;

ANTIBODIES;

ANTIBODY; BLOOD CLOTTING FACTOR 5; FIBRIN GLUE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOBLOTTING; IMMUNOLOGY; MALE; NONHUMAN; PROTEIN PURIFICATION; PROTHROMBIN TIME; RAT; SALMON; THROMBIN TIME;

ANIMALS; ANTIBODIES; BLOOD COAGULATION; C-REACTIVE PROTEIN; FACTOR VA; FEMALE; FIBRIN TISSUE ADHESIVE; HUMANS; IMMUNIZATION; IMMUNOBLOTTING; INJECTIONS, INTRAPERITONEAL; MALE; RATS; RATS, WISTAR; SALMON; THROMBIN; THROMBIN TIME;

EID: 77649204372     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32505     Document Type: Article

References (21)

1. Dunn CJ, Goa KL. Fibrin sealant: A review of its use in surgery and endoscopy. Drugs 1999;58:863-886.
2. Lee OK. Fibrin glue as a vehicle for mesenchymal stem cell delivery in bone regeneration. J Chin Med Assoc 2008;71:59-61.
3. Kalbermatten DF, Kingham PJ, Mahay D, Balcin H, Pierer G, Terenghi G. Fibrin matrix enhances adherence of peripheral nerve regenerative cells. Handchir Mikrochir Plast Chir 2008;40:75-80.
4. Kanzaki M, Yamato M, Yang J, Sekine H, Kohno C, Takagi R, Hatakeyama H, Isaka T, Okano T, Onuki T. Dynamic sealing of lung air leaks by the transplantation of tissue engineered cell sheets. Biomaterials 2007;28:4294-4302.
5. Chang J, Rasamny JJ, Park SS. Injectable tissue-engineered cartilage using a fibrin sealant. Arch Facial Plast Surg 2007;9:161-166.
6. Bruns H, Kneser U, Holzhuter S, Roth B, Kluth J, Kaufmann PM, Kluth D, Fiegel HC. Injectable liver: A novel approach using fibrin gel as a matrix for culture and intrahepatic transplantation of hepatocytes. Tissue Eng 2005;11(11/12):1718-1726.
7. Karck M, Forgione L, Haverich A. The efficacy of controlled antibiotic release for prevention of polyethyleneterephthalate-(Dacron-) related infection in cardiovascular surgery. Clin Mater 1993;13(1-4):149-154.
8. Osada T, Yamamura K, Yano K, Fujimoto K, Mizuno K, Sakurai T, Nabeshima T. Distribution and serum concentration of sisomicin released from fibrin glue-sealed dacron graft in the rat and human. J Biomed Mater Res 2000;52:53-57.
9. Simpson AE, Gilbert JA, Rudnick DE, Geroski DH, Aaberg TM Jr, Edelhauser HF. Transscleral diffusion of carboplatin: An in vitro and in vivo study. Arch Ophthalmol 2002;120: 1069-1074.
10. Tredwell S, Jackson JK, Hamilton D, Lee V, Burt HM. Use of fibrin sealants for the localized, controlled release of cefazolin. Can J Surg 2006;49:347-352.
11. Van Quill KR, Dioguardi PK, Tong CT, Gilbert JA, Aaberg TM Jr, Grossniklaus HE, Edelhauser HF, O'Brien JM. Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology 2005; 112:1151-1158.
12. Wong C, Inman E, Spaethe R, Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 2003;89:573-582.
13. Streiff MB, Ness PM. Acquired FV inhibitors: A needless iatrogenic complication of bovine thrombin exposure. Transfusion 2002;42:18-26.
14. Laidmae I, McCormick ME, Herod JL, Pastore JJ, Salum T, Sawyer ES, Janmey PA, Uibo R. Stability, sterility, coagulation, and immunologic studies of salmon coagulation proteins with potential use for mammalian wound healing and cell engineering. Biomaterials 2006;27:5771-5779.
15. Ju YE, Janmey PA, McCormick ME, Sawyer ES, Flanagan LA. Enhanced neurite growth from mammalian neurons in three-dimensional salmon fibrin gels. Biomaterials 2007;28:2097-2108.
16. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2007.
17. Michaud SE, Wang LZ, Korde N, Bucki R, Randhawa PK, Pastore JJ, Falet H, Hoffmeister K, Kuuse R, Uibo R, Herod J, Sawyer E, Janmey PA. Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants. Thromb Res 2002;107:245-254.
18. Wang LZ, Gorlin J, Michaud SE, Janmey PA, Goddeau RP, Kuuse R, Uibo R, Adams D, Sawyer ES. Purification of salmon clotting factors and their use as tissue sealants. Thromb Res 2000;100:537-548.
19. Dorion RP, Hamati HF, Landis B, Frey C, Heydt D, Carey D. Risk and clinical significance of developing antibodies induced by topical thrombin preparations. Arch Pathol Lab Med 1998;122:887-894.
20. Ortel TL, Mercer MC, Thames EH, Moore KD, Lawson JH. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin. Ann Surg 2001;233:88-96.
21. Fastenau DR, McIntyre JA. Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant. Ann Thorac Surg 2000;69:1867-1872.